NCT01600625View on ClinicalTrials.gov

Effects of Minocycline on Cytokine Levels in Severe Meibomian Gland Dysfunction

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

March 31, 2013

Conditions
Meibomian Gland Dysfunction
Interventions
DRUG

oral minocycline hydrochloride treatment

Orally received 50 mg minocycline (Minocin, SK chemical, Seoul, Korea) twice a day for 2 months treatment

Trial Locations (1)

120-752

Severance Hospital, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT01600625 - Effects of Minocycline on Cytokine Levels in Severe Meibomian Gland Dysfunction | Biotech Hunter | Biotech Hunter